Pharma may be overcoming its social media shyness. Some 115 Twitter feeds are now sponsored by drugmakers. And AstraZeneca has used one of its feeds to host a chat on how patients can save money on prescription drugs. Blog
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments